M. M. Atci Et Al. , "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study," JOURNAL OF CHEMOTHERAPY , vol.35, no.1, pp.19-28, 2023
Atci, M. M. Et Al. 2023. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. JOURNAL OF CHEMOTHERAPY , vol.35, no.1 , 19-28.
Atci, M. M., Akagunduz, B., Demir, M., Arikan, R., Ay, S., Ozer, M., ... Ayhan, M.(2023). The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. JOURNAL OF CHEMOTHERAPY , vol.35, no.1, 19-28.
Atci, Muhammed Et Al. "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study," JOURNAL OF CHEMOTHERAPY , vol.35, no.1, 19-28, 2023
Atci, Muhammed M. Et Al. "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study." JOURNAL OF CHEMOTHERAPY , vol.35, no.1, pp.19-28, 2023
Atci, M. M. Et Al. (2023) . "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study." JOURNAL OF CHEMOTHERAPY , vol.35, no.1, pp.19-28.
@article{article, author={Muhammed Mustafa Atci Et Al. }, title={The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study}, journal={JOURNAL OF CHEMOTHERAPY}, year=2023, pages={19-28} }